APA (7th ed.) Citation

Buyse, M., Saad, E. D., Burzykowski, T., Regan, M. M., & Sweeney, C. S. (2022). Surrogacy Beyond Prognosis: The Importance of “Trial-Level” Surrogacy. The oncologist (Dayton, Ohio), 27(4), 266-271. https://doi.org/10.1093/oncolo/oyac006

Chicago Style (17th ed.) Citation

Buyse, Marc, Everardo D. Saad, Tomasz Burzykowski, Meredith M. Regan, and Christopher S. Sweeney. "Surrogacy Beyond Prognosis: The Importance of “Trial-Level” Surrogacy." The Oncologist (Dayton, Ohio) 27, no. 4 (2022): 266-271. https://doi.org/10.1093/oncolo/oyac006.

MLA (9th ed.) Citation

Buyse, Marc, et al. "Surrogacy Beyond Prognosis: The Importance of “Trial-Level” Surrogacy." The Oncologist (Dayton, Ohio), vol. 27, no. 4, 2022, pp. 266-271, https://doi.org/10.1093/oncolo/oyac006.